Pulmonem Incwas Founded To Demonstrate The Effectiveness And Safety Of A Reformulated And Patented Version Of Dapsonea Generic Drugto Arrest The Development Of Inflammation Caused By Covid 19 And Help Prevent Hospitalization Of Those Who Become Infectedpulmonem Has Established Manufacturing Partnerships That Will Allow The Company To Quickly Bring This Treatment To Market Soon After Successful Completion Of Clinical Trials Pulmonem Is Also Pursuing Solutions For The Pediatric Marketas Well As Alternative Delivery Systemssuch As Nasal Sprays And Liquids
No conferences found for this company.
| Company Name | Pulmonem Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
